A Therapeutic Antibody against West Nile Virus Neutralizes Infection by Blocking Fusion within Endosomes - Wikidata - thesis-toulmin - TriplyDB

A Therapeutic Antibody against West Nile Virus Neutralizes Infection by Blocking Fusion within Endosomes

A Therapeutic Antibody against West Nile Virus Neutralizes Infection by Blocking Fusion within Endosomes

http://www.wikidata.org/entity/Q27488367

about

Mechanism and significance of cell type-dependent neutralization of flaviviruses Specificity, cross-reactivity and function of antibodies elicited by Zika virus infection Fc receptors and their influence on efficacy of therapeutic antibodies for treatment of viral diseases Capturing a Flavivirus Pre-Fusion Intermediate Effector Functions of Camelid Heavy-Chain Antibodies in Immunity to West Nile Virus Monoclonal antibody produced in plants efficiently treats West Nile virus infection in mice Peptide Inhibitors of Dengue-Virus Entry Target a Late-Stage Fusion Intermediate Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity Structural Basis of Differential Neutralization of DENV-1 Genotypes by an Antibody that Recognizes a Cryptic Epitope Structure of the St. Louis Encephalitis Virus Postfusion Envelope Trimer Structural insights into the neutralization mechanism of a higher primate antibody against dengue virus Crystal Structure of the Japanese Encephalitis Virus Envelope Protein Arbovirus Infections Protective Capacity of the Human Anamnestic Antibody Response during Acute Dengue Virus Infection A single amino acid substitution in the core protein of West Nile virus increases resistance to acidotropic compounds Hepatitis C virus induces CD81 and claudin-1 endocytosis.Dynamics of Chikungunya Virus Cell Entry Unraveled by Single-Virus Tracking in Living Cells.Safety and pharmacokinetics of single intravenous dose of MGAWN1, a novel monoclonal antibody to West Nile virus.Enhancement of anti-DIII antibodies by the C3d derivative P28 results in lower viral titers and augments protection in mice.A novel T-cell receptor mimic defines dendritic cells that present an immunodominant West Nile virus epitope in mice.Direct complement restriction of flavivirus infection requires glycan recognition by mannose-binding lectin.Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2.Antibody-induced conformational changes in herpes simplex virus glycoprotein gD reveal new targets for virus neutralization.Mechanistic study of broadly neutralizing human monoclonal antibodies against dengue virus that target the fusion loop.Human IgG subclasses: in vitro neutralization of and in vivo protection against West Nile virus.Therapeutic efficacy of antibodies lacking Fcγ receptor binding against lethal dengue virus infection is due to neutralizing potency and blocking of enhancing antibodies [corrected].A West Nile virus DNA vaccine utilizing a modified promoter induces neutralizing antibody in younger and older healthy adults in a phase I clinical trial.Antibody-mediated neutralization of flaviviruses: a reductionist view.The domain I-domain III linker plays an important role in the fusogenic conformational change of the alphavirus membrane fusion protein Potent dengue virus neutralization by a therapeutic antibody with low monovalent affinity requires bivalent engagement.Arboviral encephalitides: transmission, emergence, and pathogenesis.RNASEK is required for internalization of diverse acid-dependent viruses.Single Neutralizing Monoclonal Antibodies Targeting the VP1 GH Loop of Enterovirus 71 Inhibit both Virus Attachment and Internalization during Viral Entry Two synthetic antibodies that recognize and neutralize distinct proteolytic forms of the ebola virus envelope glycoprotein.A game of numbers: the stoichiometry of antibody-mediated neutralization of flavivirus infection.A bispecific antibody effectively neutralizes all four serotypes of dengue virus by simultaneous blocking virus attachment and fusion West Nile virus: A re-emerging pathogen revisited.High-avidity and potently neutralizing cross-reactive human monoclonal antibodies derived from secondary dengue virus infection.B cell response and mechanisms of antibody protection to West Nile virus.The human antibody response to dengue virus infection

P2860

Q23032973-8628D9C7-7F8E-4458-8E01-395979A3B8A7 Q26252507-C2537353-B252-45EC-96E0-1FA7FA53933A Q26783175-363DB507-EA7F-4142-AD8D-CB629C24C2DF Q27490389-913575C8-475B-4842-929C-F06C29937EF7 Q27490881-82012A7E-FDD9-4641-9E52-71256C240790 Q27490937-14E857F0-87FE-4D98-AF06-B41DBD63818A Q27491339-B8DC0330-464F-41DF-A3FF-EA33A1F03C27 Q27654848-AE0511CE-381F-4B1F-87FB-B0B7BF870A69 Q27674417-BA2F7C90-84DE-4F44-B771-C3D80B6CECB7 Q27674868-E2A7706B-9A1C-41A0-82B0-D76F5C3FAAB3 Q27675965-42C52F1B-4CAE-455A-9073-5858AA98F074 Q27676100-A928F58A-1125-4095-9FEE-DE4B1911C1BD Q28081847-393E3D3A-5DEF-4CE4-8234-E612B29BD47B Q28119679-3B570A75-3FC6-4192-B095-57A6A79F1A92 Q28534723-AAA5E4F9-CA23-45DE-A2CE-B2A3B4B5F7C6 Q30512696-4EAF97CE-0E42-4DD5-8DF5-22A50338A230 Q30744386-DA067835-27F1-4623-A2B5-F7F76BF82E8C Q33876476-602ECF39-BBB0-4627-87F4-7A011105BE8E Q33911897-046E5AF0-A1F1-48D5-AC7B-F092C3CB46FD Q33934227-BA285B49-FACB-49E5-853C-1A79D86322B6 Q34089838-AAEBA5C7-D912-4589-A238-047E221087AF Q34120070-1C5D09F6-EEF7-4D03-B74E-37DFE3E6AECA Q34237174-18EF3079-28CD-414B-8A7E-496574050BBB Q34306877-7B2995D4-C357-40F4-ACD6-5797B123344C Q34529911-8A2F3833-82AA-460C-8555-E8579CE64C87 Q34607919-FC380CDA-5757-49C1-9AB9-7DBAC293F246 Q34833926-259A3757-D75F-4923-9D22-930FE0330DB4 Q34999617-31B578F4-555B-4CC8-8A34-D46A3BF2C385 Q35077572-0EB03F2A-A714-4DA9-BD64-CFB761AA85B8 Q35152094-F2F2521E-0C9C-4E26-9752-44F90A168752 Q35778817-64175F9A-4574-46C4-BD4F-706330EB6BD4 Q35795990-92D45C74-FC52-45A9-B1C5-29925B806C2E Q36281127-AC9D06C2-213A-412E-8FD0-3A30D4185483 Q36934038-E22844CB-6DDE-4768-B94A-6B424AC35C54 Q37012203-4EB7F743-D4C6-4107-BF5B-D3F20B754849 Q37139005-05CBBBC5-A8C1-4FE0-8AD2-27936F81E34D Q37195527-E6618A07-8FF0-4C7D-89C5-688FB07E6A5E Q37336440-DEAA2EA4-F30D-4F97-8184-7D2409EB90E5 Q37673123-82A16DA1-6402-4051-B39B-52E31015E9D2 Q37987124-8AAE55CC-B947-4EE1-9E59-B0DDEADB2773

P2860

A Therapeutic Antibody against West Nile Virus Neutralizes Infection by Blocking Fusion within Endosomes

http://www.wikidata.org/entity/Q27488367

description

2009 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մայիսին հրատարակված գիտական հոդված

@hy

article scientifique (publié 2009-05)

@fr

articolo scientifico (pubblicato il 2009-05)

@it

artigo científico (publicado na 2009-05)

@pt

artículu científicu espublizáu en 2009

@ast

im Mai 2009 veröffentlichter wissenschaftlicher Artikel

@de

scientific article (publication date: May 2009)

@en

vedecký článok (publikovaný 2009-05)

@sk

videnskabelig artikel (udgivet 2009-05)

@da

name

A Therapeutic Antibody against ...... ocking Fusion within Endosomes

@ast

A Therapeutic Antibody against ...... ocking Fusion within Endosomes

@en

A Therapeutic Antibody against ...... ocking Fusion within Endosomes

@nl

type

label

A Therapeutic Antibody against ...... ocking Fusion within Endosomes

@ast

A Therapeutic Antibody against ...... ocking Fusion within Endosomes

@en

A Therapeutic Antibody against ...... ocking Fusion within Endosomes

@nl

prefLabel

A Therapeutic Antibody against ...... ocking Fusion within Endosomes

@ast

A Therapeutic Antibody against ...... ocking Fusion within Endosomes

@en

A Therapeutic Antibody against ...... ocking Fusion within Endosomes

@nl

P1433

Q27488367-EE93441A-6188-4723-80DF-A777B8B78C53

P1476

Q27488367-7FFDE581-AB22-454C-84B4-6172AE70D0C9

P2093

Q27488367-33CD4CE1-7C7B-4581-A296-8EE621C8A236

Q27488367-5CFA1C97-590D-4D13-8E3D-AE7E2428CE0A

Q27488367-705F83BD-684B-4992-83EE-FB6F2E0A9A3E

Q27488367-8C703A65-3937-485E-8B1E-5E70B0FEFBE4

P2860

Q27488367-07A74512-F894-4EE1-B350-DA3FBB3C1CEB

Q27488367-0A1F278D-488C-43DA-BF5D-D340D70D9C12

Q27488367-0FF89E18-BE52-44D8-8507-B5B2B3C57A81

Q27488367-1CF4C24F-C79F-4881-BB78-0FDC90B33290

Q27488367-24973011-EFED-4347-BDCC-7FE3E6F613B2

Q27488367-2531B2CB-A1BB-4CE6-B4C1-9F7C44F03D26

Q27488367-253E41C7-E410-449E-BD29-25BD1B371608

Q27488367-25F0A177-5563-4793-9FB6-CE281378E0D1

Q27488367-26FB24C5-C3AE-4539-869C-B99D3C64E276

Q27488367-29C3147D-7A1B-45CF-A043-A69B5909F806

P304

Q27488367-18A2D026-FC6E-4C35-B678-9F70E90A7104

P31

Q27488367-F3830098-BC5F-40D4-BEB9-113C7C1E18E2

P3181

Q27488367-52FE9040-C530-4F55-B8D2-AC05A2F91966

P356

Q27488367-3912AB37-0045-4AAC-B83C-C9C088C8E3B8

P433

Q27488367-E4653EB5-549F-40E6-97F5-5BACED820A63

P478

Q27488367-6D672869-705C-46A6-A082-BA83F6C11741

P50

Q27488367-09A06780-26A3-4CBD-AD0F-90B5B9E64CAC

Q27488367-B34CDE0F-3C00-43D0-BFF9-71AABAD6AB41

P577

Q27488367-7160511E-25B5-490B-9F59-FBCDE1C451E4

P5875

Q27488367-2D7F93E7-D551-42E4-AD62-C3CB11F0AFAC

P698

Q27488367-A4E23512-7B3B-4FE0-96CF-C645C295B7C5

P921

Q27488367-87F06900-C85B-416A-A301-7CF0EBEA5714

Q27488367-AF0B482D-C8C2-43E3-B8D2-FA158DE86D8F

Q27488367-DA219013-C763-42B0-83C3-E5B636AC987F

P932

Q27488367-7D2B87D0-C521-49C8-9D49-844760C6E4D4

P3181

P356

JOURNAL.PPAT.1000453

P1433

P1476

A Therapeutic Antibody against ...... ocking Fusion within Endosomes

@en

P2093

Bastiaan Moesker

http://www.w3.org/2001/XMLSchema#string

Bruce S Thompson

http://www.w3.org/2001/XMLSchema#string

Daved H Fremont

http://www.w3.org/2001/XMLSchema#string

Jolanda M Smit

http://www.w3.org/2001/XMLSchema#string

P2860

DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells

Structure of dengue virus: implications for flavivirus organization, maturation, and fusion

Mutational Evidence for an Internal Fusion Peptide in Flavivirus Envelope Protein E

Biophysical Characterization and Vector-Specific Antagonist Activity of Domain III of the Tick-Borne Flavivirus Envelope Protein

Monoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein Are the Most Efficient Blockers of Virus Adsorption to Vero Cells

West Nile Virus Discriminates between DC-SIGN and DC-SIGNR for Cellular Attachment and Infection

B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus.

Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus

Cryptic Properties of a Cluster of Dominant Flavivirus Cross-Reactive Antigenic Sites

Crystal Structure of the West Nile Virus Envelope Glycoprotein

P304

e1000453

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3132391

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PPAT.1000453

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Michael S. Diamond

P577

2009-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26249973

http://www.w3.org/2001/XMLSchema#string

P698

19478866

http://www.w3.org/2001/XMLSchema#string

P921

West Nile virus

membrane fusion involved in viral entry into host cell

P932

2679195

http://www.w3.org/2001/XMLSchema#string